Clenbuterol's dual role: asthma relief and doping controversy

Clenbuterol is a drug used mainly for asthma treatment and weight loss. While it has medical benefits, its misuse in sports and bodybuilding has led to strict regulations. The substance is banned by the World Anti-Doping Agency due to its performance-enhancing effects. Clenbuterol belongs to a group of drugs called beta2-agonists, which help relax and open the airways. Outside the U.S., doctors prescribe it for asthma and sometimes chronic obstructive pulmonary disease (COPD). The usual medical dose ranges from 0.02 to 0.03 milligrams per day, taken as a tablet or inhaler.

In the United States, clenbuterol is not approved for human use but is permitted for treating airway issues in horses. Despite this, it is often misused for weight loss or muscle building. For these purposes, doses can climb to 0.06 to 0.12 milligrams per day, taken as tablets, liquids, or injections. The drug’s ability to boost muscle growth and reduce fat has made it popular in livestock farming and among athletes. However, misuse can cause serious side effects, including a rapid heart rate, breathing difficulties, chest pain, and anxiety. Traces of clenbuterol can remain in the body for about six days, with detection possible for even longer.

Clenbuterol’s dual role as a medical treatment and a performance-enhancing drug has led to tight controls. Its presence on the World Anti-Doping Agency’s banned list highlights the risks of misuse. Those using it without supervision face potential health dangers and regulatory consequences.